Angiodynamics Inc Revenue Growth Rates (ANGO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Angiodynamics Inc   (NASDAQ: ANGO)
 

ANGO's Revenue Growth by Quarter and Year

Angiodynamics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ANGO/growth
https://api.csimarket.com/api/v1/companies/ANGO/fundamentals
https://api.csimarket.com/api/v1/companies/ANGO/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
ANGO Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter May -
3rd Quarter February -
2nd Quarter November -
1st Quarter August 80.92
FY 80.92

ANGOs Annual Revenue
Angiodynamics Inc 's Revenue in the fiscal year 2026 $ 320.17 millions
Angiodynamics Inc 's Revenue in the fiscal year 2025 $ 291.71 millions
Angiodynamics Inc 's Revenue in the fiscal year 2024 $ 303.70 millions
Angiodynamics Inc 's Revenue in the fiscal year 2023 $ 338.25 millions
Angiodynamics Inc 's Revenue in the fiscal year 2022 $ 316.22 millions




ANGO Revenue first quarter 2026 Y/Y Growth Comment
Angiodynamics Inc achieved in the first quarter 2026, above Company average Revenue improvement of 8.09% year on year, to $ 80.92 millions.

Looking into first quarter 2026 results within Medical Equipment & Supplies industry 100 other companies have achieved higher Revenue growth. While Angiodynamics Inc ' s Revenue increase of 8.09% ranks overall at the positon no. 1982 in the first quarter 2026.


ANGO Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter May -
3rd Quarter February -
2nd Quarter November -
1st Quarter August 8.09 %
FY   -

Financial Statements
Angiodynamics Inc 's first quarter 2026 Revenue $ 80.92 millions ANGO's Income Statement
Angiodynamics Inc 's first quarter 2025 Revenue $ 74.86 millions Quarterly ANGO's Income Statement


ANGO Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter May -
3rd Quarter February -
2nd Quarter November -
1st Quarter August -6.58 %
FY (Year on Year)   -


Back to ANGO Growth rate Comparisons >> Back to ANGO Growth rate Comparisons >>


Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #101
Healthcare Sector #294
Overall #1982

Revenue Y/Y Growth Statistics
High Average Low
63.04 % 3.94 % -25.13 %
 
Revenue first quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #101
Healthcare Sector #294
Overall #1982
Revenue Y/Y Growth Statistics
High Average Low
63.04 % 3.94 % -25.13 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Angiodynamics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
44.58 % 1.14 % -21.06 %
(Aug 31 2012)  


ANGO's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Angiodynamics Inc disclosed decline in Revenue from the fourth quarter by -6.58% to $ 80.92 millions, from $ 86.61 millions achived in the previous reporting period.

But that's not important problem, as Angiodynamics Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 101 other companies have achieved higher Revenue quarter on quarter growth. While Angiodynamics Inc 's Revenue growth quarter on quarter, overall rank is 2684.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #102
Healthcare Sector #331
Overall #2684
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #102
Healthcare Sector #331
Overall #2684
Revenue Q/Q Growth Statistics
High Average Low
44.58 % 1.14 % -21.06 %
(Aug 31 2012)  


ANGO's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Angiodynamics Inc disclosed decline in Revenue from the fourth quarter by -6.58% to $ 80.92 millions, from $ 86.61 millions achived in the previous reporting period.

But that's not important problem, as Angiodynamics Inc 's Revenue generally seem to plunge in this quarter.

Within Medical Equipment & Supplies industry 101 other companies have achieved higher Revenue quarter on quarter growth. While Angiodynamics Inc 's Revenue growth quarter on quarter, overall rank is 2684.


Angiodynamics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Aug 31 2026)		 12 Months Ending (May 31 2026) 12 Months Ending (Feb 28 2026) 12 Months Ending (Nov 30 2025) 12 Months Ending (Aug 31 2025)
Cumulative Revenue 12 Months Ending $ 323.78
Y / Y Revenue Growth (TTM) 8.37 %
Year on Year Revenue Growth Overall Ranking # 1457
Seqeuential Revenue Change (TTM) 1.91 %
Seq. Revenue Growth (TTM) Overall Ranking # 1457


Cumulative Revenue growth Comment
Assuming the Angiodynamics Inc 's fiscal year would have ended in Aug 31 2026, Angiodynamics Inc would have reprted above average annual Revenue improvement of 8.37% year on year, of $ 324 millions.
This marks a slow-down of the companys growth trends and from the 9.32% growth in May 31 2026.

In the Healthcare sector 335 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1457, from total ranking in previous quarter at 2040.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 125
Healthcare Sector # 336
Overall # 2359

Revenue TTM Y/Y Growth Statistics
High Average Low
56.03 %
 3.33 %
-22.53 %
(May 31 2013)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 336
S&P 500 # 2350
Cumulative Revenue growth Comment
Assuming the Angiodynamics Inc 's fiscal year would have ended in Aug 31 2026, Angiodynamics Inc would have reprted above average annual Revenue improvement of 8.37% year on year, of $ 324 millions.
This marks a slow-down of the companys growth trends and from the 9.32% growth in May 31 2026.

In the Healthcare sector 335 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 1457, from total ranking in previous quarter at 2040.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 125
Healthcare Sector # 336
Overall # 2359

Revenue TTM Y/Y Growth Statistics
High Average Low
56.03 %
3.33 %
-22.53 %
(May 31 2013)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 336
S&P 500 # 2350




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ANGO's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Aug 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Aug 31 2026
Angiodynamics Inc 8.09%$ 8.093 millions
Neogen Corporation6.67%$ 6.666 millions


About Angiodynamics Inc Revenue Growth Rates (ANGO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Angiodynamics Inc (CIK 1275187).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-065423
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Angiodynamics Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.